International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7945425
Original Article
Outbreak Investigation by “Disease Detectives”: A Retrospective Analysis of Hospital Infection Control Practices
 ,
 ,
 ,
 ,
Published
May 17, 2023
Abstract
Introduction: Outbreaks in the intensive care units have a devastating impact in any healthcare setting, especially Tertiary care hospitals. Conventionally, outbreaks have been described using the “shoe leather” approach. Understanding of emerging infectious microorganisms requires laboratory isolation as a vital tool in investigation of outbreaks. Notorious microorganisms are commonly associated with such outbreaks. This requires “disease detectives” to maintain a constant vigil. Material & methods: In this analytical study we summarize five outbreaks at our Tertiary care centre over a period of 18 months. The outbreaks were investigated by the Infection control team following the recommendations of CDC (10 step approach ). Results & Discussion: Three outbreaks occurred in the adult intensive care unit (ICU). Gram negative organisms (Acinetobacter spp & Chryseobacteriumindologenes) predominated as etiological agents(66%) from blood, urine and endotracheal tube aspirates. All outbreaks in the Neonatal ICUs were caused by Acinetobacter spp., which was isolated from blood samples of neonates. Despite our vigorous efforts the source was identified only in one outbreak. Significant mortality was seen in all outbreaks (probably multifactorial). Conclusion: A constant scrutiny especially in the high risk areas can help in limiting the number of cases and timely intervention cannot let the micro-organisms escape unfathomed.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
128 Views
411 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved